Colonoscopy Data Collection Form



Similar documents
How to Effectively Code for Endoscopic Procedures in Gastroenterology

Billing Guideline. Subject: Colorectal Cancer Screening Exams (Invasive Procedures) Effective Date: 1/1/2012 Last Update Effective: 4/16

Estimated Population Responding on Item 25,196,036 2,288,572 3,030,297 5,415,134 4,945,979 5,256,419 4,116,133 Medicare 39.3 (0.2)

This letter can be copied and pasted in a word document for use with your letterhead.

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

COLORECTAL CANCER SCREENING

Early Colonoscopy in Patients with Acute Diverticulitis Simon Bar-Meir, M.D.

Total Males Females (0.4) (1.6) Didn't believe entitled or eligible 13.0 (0.3) Did not know how to apply for benefits 3.4 (0.

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Risk stratification for colorectal cancer especially: the difference between sporadic disease and polyposis syndromes. Dr. med. Henrik Csaba Horváth

PATIENT INFORMATION INTAKE F O R M BESSMER CHIROPRACTIC P. C.

There are 5 demographic data elements that include gender, date of birth, race, ethnicity status,

LOWER GI ENDOSCOPIES So why is CMS yanking our chain? General Concepts for all GI Endoscopy Procedures

The Forzani MacPhail Colon Cancer Screening Centre Frequently Asked Questions. What is the Forzani MacPhail Colon Cancer Screening Centre?

Epi procolon The Blood Test for Colorectal Cancer Screening

Cancer Screening and Early Detection Guidelines

By Anne C. Travis, M.D., M.Sc. and John R. Saltzman, M.D., FACG Brigham and Women's Hospital Harvard Medical School Boston, MA

Measure Name: Follow-Up After Initial Diagnosis and Treatment Of Colorectal Cancer: Colonoscopy Owner: NQF (#0572)

Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions

As Reported by the Senate Health, Human Services and Aging Committee. 127th General Assembly Regular Session Sub. S. B. No A B I L L

Vascular Quality Initiative - Carotid Artery Stent. Last Name First Name Middle Initial

Please bring the following with you to your appointment: Completed New Patient forms A list of all prescribed medications with dosages and quantity

Gastrointestinal Bleeding

MD-REPORTS. Comprehensive, specialty specific one stop solution for Office, Ambulatory and Hospital electronic document requirements

Connecticut Diabetes Statistics

Rural Health Information Technology Cooperative. Clinician Survey on Quality Improvement, Best Practice Guidelines, and Information Technology

Patient Registration Form

MU Inpatient Consult Rotation

Improving Colorectal Cancer Screening and Outcomes using an EMR Automation Model

Behavioral Health Barometer. United States, 2013

The Two Sides of Gastroenterology

Provincial Quality Management Programs for Mammography, Colonoscopy and Pathology in Ontario

By James D. Gould, MD FACS

Demographics. MBSAQIP Case Number: IDN: ACS NSQIP Case Number:

What is Barrett s esophagus? How does Barrett s esophagus develop?

Clinic Readiness Survey Leadership

Clinical Indicator Ages Ages Ages Ages Ages 65+ Frequency of visit as recommended by PCP

Screening guidelines tool

Colon Cancer. What Is Colon Cancer? What Are the Screening Methods?

Who? Physicians, physician groups, health care services, health care professionals

Screening for colorectal cancer (CRC) in asymptomatic patients

South Dakota DOE Report Card

2. What HCPCS Level II code describes Ensure HN therapy with an enteral infusion pump with alarm?

2015 Medicare Physician Fee Schedule Putting the Pieces Together for GI Colleen M. Schmitt, MD, MHA, FASGE ASGE President

Case Presentation: Diminutive polyps. Siwan Thomas-Gibson St. Marks Hospital London UK

Colon and Rectal Cancer

Cancer Screening 22M 36% 56% Only 56% of uninsured women aged are up-to-date with mammography screening. Colorectal Cancer Breast Cancer

Your appointment is scheduled for at with Dr. Your arrival time is.

Colorectal Cancer Care A Cancer Care Map for Patients

EVIDENCE BASED TREATMENT OF CROHN S DISEASE. Dr E Ndabaneze

Ophthalmology Meaningful Use Attestation Guide Stage Edition

C-CoP (1B1b) Results, Procedure-Based Report for Colorectal Cancer Screening by Jurisdiction

Complications of pediatric endoscopy and colonoscopy. Informed consent. Learning objectives. Complication types. Complications (adults) 10/3/2012

Bryant T. Aldridge Rehabilitation Center Unit Specific Inclusive Diversity Analysis: CULTURAL COMPETENCY AND DIVERSITY PLAN February 2015

Laparoscopic Colectomy. What do I need to know about my laparoscopic colorectal surgery?

Developing an endoscopic mucosal resection service in a district general hospital

Table of Contents Forward... 1 Introduction... 2 Evaluation and Management Services... 3 Psychiatric Services... 6 Diagnostic Surgery and Surgery...

Electronic Health Records Intake Form

This publication was developed and produced with funding from the Centers for Disease Control and Prevention under a cooperative agreement.

Blood-based SEPT9 Test in Colorectal Cancer Detection

Date of Birth: Home Ph. #: Cell Ph. #:

9/12/2014. Advancing The Practice Of Advanced Practice Nursing. Can A Nurse Practitioner Perform Endoscopy? A Personal Journey

FAQ About Prostate Cancer Treatment and SpaceOAR System

Survey of Team Attitudes and Relationships (STAR)

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

Travel Distance to Healthcare Centers is Associated with Advanced Colon Cancer at Presentation

STRONG CENTER FOR DEVELOPMENTAL DISABILITIES TRAINEE APPLICATION FORM

Surgical Chart Auditing. Agenda

X-ray (Radiography), Lower GI Tract

United States Military Casualty Statistics: Operation Iraqi Freedom and Operation Enduring Freedom

Problems of the Digestive System

Flexible sigmoidoscopy the procedure explained Please bring this booklet with you

REGISTRATION FORM. How would you like to receive health information? Electronic Paper In Person. Daytime Phone Preferred.

FEATURES NETWORK OUT-OF-NETWORK

2015 PSYCHOLOGIST BIENNIAL RENEWAL

Colorectal Cancer Screening: Update on Bowel Preps

Patient information on endoscopic mucosal resection (EMR) (Endoscopic removal of polyps) Your questions answered

Challenges in gastric, appendiceal and rectal NETs Leuven,

Transcription:

Identifier: Sociodemographic Information Type: Zip Code: Gender: Height: (inches) Race: Ethnicity Inpatient Outpatient Male Female Birth Date: Weight: (pounds) American Indian (Native American) or Alaska Native Asian Black or African American Native Hawaiian or Other Pacific Islander White declined to provide Unknown Other Hispanic or Latino Not Hispanic or Latino declined to provide Unknown m m d d y y y y Insurance Type: Aetna Blue Cross/Blue Shield Cigna Humana United Healthcare Wellpoint Medicare Advantage Medicare Fee for Service Medicaid Tricare None Other (list specific name of plan if not listed above): GIQuIC CRF Page 1 of 7

Endoscopy Facility ID: Physician ID (NPI): Fellow Physician ID (NPI): Year of Fellowship Procedure Date: Year 1 Year 2 Year 3 Year 4 Endoscopy Suite Information General Quality Indicators Endo Suite Type: Hospital ASC/AEC Physician Office Endo Suite Teaching Facility Teaching Non-Teaching Facility Status: Did the Fellow Yes Physician perform the No procedure? Physician Specialty GI IM FP Surgeon Other m m d d y y y y Endoscopy Procedure: Colonoscopy EGD Current History & Physical Documented on Chart? Yes No Informed Consent Documented in Medical Record? Yes No ERCP EUS ASA Category: ASA I ASA II ASA III ASA IV ASA V ASA-E Sedation type: None Moderate Deep (propofol) General Sedation administered by: Nurse Endoscopist Anesthesia professional Discharge Instructions Note: If the procedure is for an inpatient, please fill out only the questions on Diet Instructions and Medication Resumption. If the procedure is for an outpatient, please fill out all the instruction questions below. Written Discharge Instructions provided to patient before discharge? Yes No Diet Instructions: Yes No GIQuIC CRF Page 2 of 7

Medication Resumption / Orders Given: Yes No N/A Return to Activities: Yes No Potential Delayed Complications: Yes No Medical Emergency Contact Number: Yes No Anticoagulation / Anti-platelet Therapy Anticoagulation / Anti-platelet Therapy: given instructions relative to resumption of therapy Yes No N/A Colonoscopy Type: Colonoscopy Procedure Quality Indicators Colon Cancer Screening Surveillance Diagnostic If Screening or Surveillance, Year of previous colonoscopy: y y y y Bowel Prep Quality: (Bowel Prep is adequate if sufficient to accurately detect polyps 6 mm in size; Inadequate if it is NOT sufficient to accurately detect polyps > 6 mm) Adequate Inadequate Colonoscopy Indication Select at least one (1) reason for performing the colonoscopy Evaluation of unexplained GI bleeding Unexplained iron deficiency anemia Screening for colonic neoplasia Surveillance due to prior colonic neoplasia Inflammatory bowel disease of the intestine if more precise diagnosis or determination of the extent / severity of activity of disease will influence immediate / future management Clinically significant diarrhea of unexplained origin Evaluation of barium enema or other imaging study of an abnormality that is likely to be clinically significant, such as filling defect or stricture Intraoperative identification of a lesion not apparent/found at surgery (e.g. polypectomy site or bleeding source) GIQuIC CRF Page 3 of 7

Treatment of bleeding from such lesions as vascular malformation, ulceration, neoplasia, & polypectomy site Foreign body removal Excision of colonic polyp Decompression of an acute nontoxic megacolon or sigmoid volvulus Balloon dilation of stenotic lesions Palliative treatment of stenosing or bleeding neoplasms Marking a neoplasm for localization Other, specify: Cecal Landmarks Documentation provided in medical record Ileocecal Valve Photographed Yes No Appendiceal Orifice Photographed Yes No Terminal Ileum Photographed Yes No Colorectal Neoplasm Risk Assessment for this procedure: If High Risk, select all that apply: Colon or Rectal Adenocarcinoma, specify(c): Colorectal Neoplasm Risk Assessment Average Risk High Risk N/A Personal History Family History (1 st degree relative < 60 years old) Both History of Colon Adenoma, specify (c): Personal History Family History (1 st degree relative < 60 years old with advanced adenoma(s)) Both High Risk Genetic Family Cancer Syndrome (e.g. Familial Adenomatous Polyposis Syndrome, HNPCC/Lynch Syndrome,) (c) Personal History Family History Both Advanced Neoplasm ( 10 mm, high grade dysplasia, villous component (c) GIQuIC CRF Page 4 of 7

3 or More Adenomas (c) Non Advanced Neoplasm (< 3 adenomas, < 10 mm, no villous component) (c) Sessile serrated polyp(s) < 10 mm with no dysplasia (c) Personal History Family History (1 st degree relative < 60 years old) Both Sessile serrated polyp 10 mm OR sessile serrated polyp with dysplasia OR traditional serrated adenoma (c) Personal History Serrated polyposis syndrome* (c) Family History (1 st degree relative < 60 years old) Both Personal History Family History (1 st degree relative < 60 years old) Both *Based on the World Health Organization definition of serrated polyposis syndrome, with one of the following criteria: (1) at least 5 serrated polyps proximal to sigmoid, with 2 or more 10 mm; (2) any serrated polyps proximal to sigmoid with family history of serrated polyposis syndrome; and (3) > 20 serrated polyps of any size throughout the colon. Inflammatory Bowel Disease ( 8 years pancolitis or 15 years left sided colitis) (c) Inflammatory Bowel Disease with Known Dysplasia Polyps Number of Polyps Removed During Colonoscopy Procedure: Number Polyps Partially Removed During Colonoscopy Procedure: Number Polyps Retrieved During Colonoscopy Procedure: Polyp Morphology Described: Polyp Size Described: Yes No N/A Yes No N/A GIQuIC CRF Page 5 of 7

Procedure Duration Specify the number of minutes required to complete the following: (ie: 7.4 min) Please note: Dummy Codes should be used when cecum is not reached: 5555.0 - No Cecum, 7777.0- Did not reach Cecum, 8888.0 -Time not documented, 9999.0 Hemicolectomy) Time between insertion and reaching the cecum (in minutes): Withdrawal time from Cecum to anus (in minutes): Pathology Tissue Obtained? Pathology Yes No If Yes, Select All Polyps That Apply Adenomatous Polyp(s): (select all that apply) None < 3 Months 3 Months 6 Months 9 Months If Adenomatous Polyp(s) - Select All That Apply 1 or 2 Tubular Adenomas < 10 mm 3 or More Adenomas Advanced Neoplasm ( 10 mm, high grade dysplasia, villous component) Adenocarcinoma Serrated Lesions (select all that apply) Sessile serrated polyp(s) < 10 mm with no dysplasia Sessile serrated polyp 10 mm OR sessile serrated polyp with dysplasia OR traditional serrated adenoma Hyperplastic Polyp(s) Other, specify: Follow-up Interval Select follow-up interval for next Colonoscopy 1 Year Other: 2 Years 3 Years 5 Years 10 Years Follow-up Interval for Next Colonoscopy Changed Due to Bowel Preparation? GIQuIC CRF Page 6 of 7

Adverse Events Please specify immediate adverse events(s) occurring the same day, before the patient leaves the endoscopy facility No Adverse Events Bowel Perforation Bleeding (Unplanned Intervention or Hospital Admission) Emergency Dept visit related to colonoscopy procedure Hospital Admission related to colonoscopy procedure Sedation Related (Unplanned Intervention) Death Other, specify: GIQuIC CRF Page 7 of 7